US Patent Issued to Cyclacel Pharmaceuticals on Jan. 27 for "Crystalline forms of pyrimidino diazepine derivative" (British Inventors)

ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,466, issued on Jan. 27, was assigned to Cyclacel Pharmaceuticals Inc. (Berkeley Heights, N.J.).

"Crystalline forms of pyrimidino diazepine derivative" was invented by Benjamin Skead (Cambridge, Great Britain), Julian Northen (South Shields, Great Britain), Chris Atherton (Durham, Great Britain) and John Mykytiuk (Houghton le Spring, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to new crystalline forms of a pyrimido-diazepine derivative which exhibits excellent anti-tumour activity. The invention also relates to a pharmaceutical composition containing said crystalline forms as an active ingredient, and us...